Erki Enkvist

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 6

Top Topics

Photodynamic Therapy

Crystal Structure

Fluorescent Probe

Top Venues

Molecules (Basel, Switzerland)

Bioscience, biotechnology, and biochemistry

Chemical communications (Cambridge, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Tanel Sõrmus, Darja Lavogina, Anu Teearu, Erki Enkvist, Asko Uri, Kaido Viht
Construction of Covalent Bisubstrate Inhibitor of Protein Kinase Reacting with Cysteine Residue at Substrate-Binding Site. Journal of medicinal chemistry 65 (16) (2022)
Tanel Sõrmus, Darja Lavogina, Erki Enkvist, Asko Uri, Kaido Viht
Deactivatable Bisubstrate Inhibitors of Protein Kinases. Molecules (Basel, Switzerland) 27 (19) (2022)
Olivier Etebe Nonga, Darja Lavogina, Erki Enkvist, Katrin Kestav, Apirat Chaikuad, Sarah E Dixon-Clarke, Alex N Bullock, Sergei Kopanchuk, Taavi Ivan, Ramesh Ekambaram, Kaido Viht, Stefan Knapp, Asko Uri
Crystal Structure-Guided Design of Bisubstrate Inhibitors and Photoluminescent Probes for Protein Kinases of the PIM Family. Molecules (Basel, Switzerland) 26 (14) (2021)
Olivier Etebe Nonga, Erki Enkvist, Friedrich W Herberg, Asko Uri
Inhibitors and fluorescent probes for protein kinase PKAcβ and its S54L mutant, identified in a patient with cortisol producing adenoma. Bioscience, biotechnology, and biochemistry 84 (9) (2020)
Tanel Sõrmus, Darja Lavogina, Erki Enkvist, Asko Uri, Kaido Viht
Efficient photocaging of a tight-binding bisubstrate inhibitor of cAMP-dependent protein kinase. Chemical communications (Cambridge, England) 55 (74) (2019)
Hedi Rahnel, Kaido Viht, Darja Lavogina, Olga Mazina, Tõiv Haljasorg, Erki Enkvist, Asko Uri
A Selective Biligand Inhibitor of CK2 Increases Caspase-3 Activity in Cancer Cells and Inhibits Platelet Aggregation. ChemMedChem 12 (20) (2017)